Joshua McGee, Ph.D.

Joshua is a former Wong Lab Graduate student, and the CSO of Keylicon Biosciences. Josh’s research in the group spearheaded the development and application of self-amplifying RNA (saRNA) for a variety of therapeutic and genetic engineering modalities, from vaccines to anti-cancer treatments and beyond (McGee, Kirsch et al. Nature Biotech 2024). Josh is the recipient of several awards, including the prestigious NSF Graduate Research Fellowship, as well as Boston University’s Translational Research in Biomaterials Fellowship. Since graduating, Josh has been working as the CSO of Keylicon, a BU spin out built off of his saRNA work which hopes to translate the innovative findings of his research into more effective RNA therapies for patients. When he isn’t working hard in the lab, Josh is a devoted family-man spending time with his wife and family, and is an avid fan of Boston sports. He also can bake a mean chocolate chip cookie.